QPharma Continues to Expand KOL Mapping and Targeting Footprint

Another Global Pharmaceutical Giant Joins Titanium® Client Roster

MORRISTOWN, N.J.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/pharma?src=hash” target=”_blank”gt;#pharmalt;/agt;–QPharma, a premier provider of commercial and compliance services to the
life sciences industry, has been engaged by several new clients in 2019,
including a Top 15 pharmaceutical manufacturer, to provide a global KOL
engagement and HCP targeting solution.

QPharma will enhance its new client’s medical and promotional
communication in the field by creating a comprehensive KOL/HCP
engagement and targeting strategy for the oncology medical and
commercial teams. The program will span nearly a dozen countries in
Latin America and the Middle East, along with the entirety of North
America. The news follows last year’s announcement of the exponential
growth of QPharma’s KOL and HCP targeting services in North America and
Europe.

Pharmaceutical companies routinely identify Key Opinion Leaders (KOLs),
also known as thought leaders, to support communication activities
around their brands. KOLs are typically physicians and other healthcare
providers (HCPs) that are highly influential within their fields. A
pioneering force in thought leader engagement and influence mapping,
QPharma has developed the Ti KOL® and Ti Target® solutions, part of the
Titanium® platform of commercial and compliance tools.

In the execution of these programs, QPharma’s team of more than 300
medical researchers analyze and score KOLs using QPharma’s proprietary
algorithms, creating an influence map to help clients understand the
influence of KOLs and their networks. This targeted, analytics-driven
approach results in a highly targeted promotional plan that enables
clients to more effectively message HCPs and promote their therapies.

“QPharma offers the most comprehensive and revolutionary solution for
KOL engagement and HCP targeting currently available on the market,”
said Badal Shah, Managing Director for KOL, HCP Targeting & Opioid Risk,
who leads this practice at QPharma. “We look forward to continuing to
expand our global footprint, as more pharmaceutical brands take
advantage of the enormous benefits these novel methodologies, tools, and
services can offer them.”

About QPharma, Inc.

Founded in 1994, QPharma is the industry leader in cloud-based software and
services for life sciences. The Commercial Services division provides
solutions that include sample management and distribution, product
launch management, online training, and HCP/KOL targeting and
engagement. Services offered by the company’s Professional Services
division include validation services, project management, auditing, and
training. QPharma is a National Association of Boards of Pharmacy
Verified Accredited Wholesale Distributor, and an approved American
Medical Association Database Licensee. For more information, visit www.qpharmacorp.com.

Contacts

Brendan Middleton, VP of Marketing and Communications
(973) 656-0011
[email protected]

error: Content is protected !!